1. Home
  2. ALKS vs CWAN Comparison

ALKS vs CWAN Comparison

Compare ALKS & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • CWAN
  • Stock Information
  • Founded
  • ALKS 1987
  • CWAN 2004
  • Country
  • ALKS Ireland
  • CWAN United States
  • Employees
  • ALKS N/A
  • CWAN N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • CWAN Computer Software: Prepackaged Software
  • Sector
  • ALKS Health Care
  • CWAN Technology
  • Exchange
  • ALKS Nasdaq
  • CWAN Nasdaq
  • Market Cap
  • ALKS 5.1B
  • CWAN 5.9B
  • IPO Year
  • ALKS 1991
  • CWAN 2021
  • Fundamental
  • Price
  • ALKS $28.61
  • CWAN $21.93
  • Analyst Decision
  • ALKS Buy
  • CWAN Buy
  • Analyst Count
  • ALKS 12
  • CWAN 10
  • Target Price
  • ALKS $40.00
  • CWAN $31.50
  • AVG Volume (30 Days)
  • ALKS 1.6M
  • CWAN 4.4M
  • Earning Date
  • ALKS 07-23-2025
  • CWAN 07-30-2025
  • Dividend Yield
  • ALKS N/A
  • CWAN N/A
  • EPS Growth
  • ALKS N/A
  • CWAN N/A
  • EPS
  • ALKS 2.09
  • CWAN 1.71
  • Revenue
  • ALKS $1,513,770,000.00
  • CWAN $475,948,000.00
  • Revenue This Year
  • ALKS N/A
  • CWAN $63.43
  • Revenue Next Year
  • ALKS $4.25
  • CWAN $29.94
  • P/E Ratio
  • ALKS $13.70
  • CWAN $12.76
  • Revenue Growth
  • ALKS N/A
  • CWAN 23.21
  • 52 Week Low
  • ALKS $22.90
  • CWAN $17.63
  • 52 Week High
  • ALKS $36.45
  • CWAN $35.71
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 35.94
  • CWAN 44.17
  • Support Level
  • ALKS $29.26
  • CWAN $21.70
  • Resistance Level
  • ALKS $29.53
  • CWAN $22.47
  • Average True Range (ATR)
  • ALKS 0.71
  • CWAN 0.74
  • MACD
  • ALKS -0.18
  • CWAN -0.03
  • Stochastic Oscillator
  • ALKS 3.64
  • CWAN 20.91

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About CWAN Clearwater Analytics Holdings Inc.

Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.

Share on Social Networks: